NCT02609399View on ClinicalTrials.gov

ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

May 26, 2017

Study Completion Date

May 31, 2018

Conditions
Influenza
Interventions
DRUG

Oseltamivir

Oral

DRUG

Peramivir

"IV~Note: Subjects admitted to the hospital directly from the ED Enrollment Visit may receive more doses at the discretion of the treating physician."

Trial Locations (2)

21287

Johns Hopkins Hospital, Baltimore

85008

Maricopa Integrated Health System, Phoenix

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Johns Hopkins University

OTHER

NCT02609399 - ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir | Biotech Hunter | Biotech Hunter